Starget Pharma key facts
- Operator of a biotechnology company intended to specialize in the diagnosis and targeted treatment of cancer using targeted radioactive radiation.
- It has raised $37.3M across 1 recorded rounds; the latest was Early Stage VC ($16.4M) in Jan 2026.
- Notable investors include Louisiana Economic Development, 2b AHEAD Ventures, ARC Innovation Center, BRF(Shreveport), BVM Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch Starget Pharma: the Monday email on marks, rounds and moves
Starget Pharma funding rounds
1 roundsHow much has Starget Pharma raised?
Starget Pharma has raised $37.3 million in total; 1 of its rounds is on record. The largest on record was a $16.4 million early-stage round in Jan 2026.
Starget Pharma investors
8 investors are on record for Starget Pharma, including Louisiana Economic Development, 2b AHEAD Ventures, ARC Innovation Center and BRF(Shreveport). The early-stage round in Jan 2026 drew 29 investors.
About Starget Pharma
Operator of a biotechnology company intended to specialize in the diagnosis and targeted treatment of cancer using targeted radioactive radiation. The company's research is in the development of molecules that serve as a vector for the targeted transfer of radioactive isotopes to cancerous tumors, where there is an unmet medical need, enabling doctors and medical practitioners to provide effective treatment for cancer.
- Sector
- Healthcare
- HQ
- Ramat HaSharon, Israel
- Founded
- 2019
- Employees
- 18
- Website
- stargetpharma.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Starget Pharma doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.